These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 9402314)
1. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein. Pétriz J; Sánchez J; Bertrán J; García-López J Anticancer Drugs; 1997 Oct; 8(9):869-75. PubMed ID: 9402314 [TBL] [Abstract][Full Text] [Related]
2. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment. Jetté L; Murphy GF; Béliveau R Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733 [TBL] [Abstract][Full Text] [Related]
3. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents. Jachez B; Loor F Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300 [TBL] [Abstract][Full Text] [Related]
4. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells. Lautier D; Canitrot Y; Salmon JM Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686 [TBL] [Abstract][Full Text] [Related]
5. Decreased potency of MDR-modulators under serum conditions determined by a functional assay. Ludescher C; Eisterer W; Hilbe W; Hofmann J; Thaler J Br J Haematol; 1995 Nov; 91(3):652-7. PubMed ID: 8555069 [TBL] [Abstract][Full Text] [Related]
6. Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446. Jachez B; Nordmann R; Loor F J Natl Cancer Inst; 1993 Mar; 85(6):478-83. PubMed ID: 8095304 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786 [TBL] [Abstract][Full Text] [Related]
8. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833. Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208 [TBL] [Abstract][Full Text] [Related]
9. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein. Archinal-Mattheis A; Rzepka RW; Watanabe T; Kokubu N; Itoh Y; Combates NJ; Bair KW; Cohen D Oncol Res; 1995; 7(12):603-10. PubMed ID: 8704277 [TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of P-glycoprotein as a determinant of loading with fluorescent calcium probes. Brezden CB; Hedley DW; Rauth AM Cytometry; 1994 Dec; 17(4):343-8. PubMed ID: 7875042 [TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129 [TBL] [Abstract][Full Text] [Related]
14. Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype. te Boekhorst PA; van Kapel J; Schoester M; Sonneveld P Cancer Chemother Pharmacol; 1992; 30(3):238-42. PubMed ID: 1352739 [TBL] [Abstract][Full Text] [Related]
15. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein. Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401 [TBL] [Abstract][Full Text] [Related]
16. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by a cyclosporin D analogue PSC 833]. Dai H; Luo S; Yin A; Peng A Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):23-6. PubMed ID: 12015084 [TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of P-glycoprotein function using rhodamine 123. Pétriz J; García-López J Leukemia; 1997 Jul; 11(7):1124-30. PubMed ID: 9205001 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites. Demeule M; Laplante A; Sepehr-Araé A; Beaulieu E; Averill-Bates D; Wenger RM; Béliveau R Biochem Cell Biol; 1999; 77(1):47-58. PubMed ID: 10426286 [TBL] [Abstract][Full Text] [Related]
19. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers. Pilarski LM; Yatscoff RW; Murphy GF; Belch AR Leukemia; 1998 Apr; 12(4):505-9. PubMed ID: 9557608 [TBL] [Abstract][Full Text] [Related]
20. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells. Davey MW; Hargrave RM; Davey RA Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]